These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 11234887
21. MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism. Pei XY, Dai Y, Tenorio S, Lu J, Harada H, Dent P, Grant S. Blood; 2007 Sep 15; 110(6):2092-101. PubMed ID: 17540843 [Abstract] [Full Text] [Related]
24. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC, Chung JG. J Pharmacol Exp Ther; 2010 Aug 15; 334(2):477-88. PubMed ID: 20463006 [Abstract] [Full Text] [Related]
25. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K. Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993 [Abstract] [Full Text] [Related]
27. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells. Maggio SC, Rosato RR, Kramer LB, Dai Y, Rahmani M, Paik DS, Czarnik AC, Payne SG, Spiegel S, Grant S. Cancer Res; 2004 Apr 01; 64(7):2590-600. PubMed ID: 15059916 [Abstract] [Full Text] [Related]
30. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH. Clin Cancer Res; 2003 Oct 15; 9(13):5018-27. PubMed ID: 14581377 [Abstract] [Full Text] [Related]
32. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. Rahmani M, Reese E, Dai Y, Bauer C, Payne SG, Dent P, Spiegel S, Grant S. Cancer Res; 2005 Mar 15; 65(6):2422-32. PubMed ID: 15781658 [Abstract] [Full Text] [Related]
33. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K. Cell Growth Differ; 1996 Dec 15; 7(12):1617-23. PubMed ID: 8959329 [Abstract] [Full Text] [Related]
34. Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2. Dasmahapatra G, Almenara JA, Grant S. Mol Pharmacol; 2006 Jan 15; 69(1):288-98. PubMed ID: 16219908 [Abstract] [Full Text] [Related]
36. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity. Le XF, Marcelli M, McWatters A, Nan B, Mills GB, O'Brian CA, Bast RC. Oncogene; 2001 Dec 13; 20(57):8258-69. PubMed ID: 11781840 [Abstract] [Full Text] [Related]
38. Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes. Takagi K, Kawai Y, Yamauchi T, Ueda T. Biochem Pharmacol; 2004 Nov 01; 68(9):1757-66. PubMed ID: 15450941 [Abstract] [Full Text] [Related]
39. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity. Kuo ML, Shen SC, Yang CH, Chuang SE, Cheng AL, Huang TS. Oncogene; 1998 Oct 29; 17(17):2225-34. PubMed ID: 9811453 [Abstract] [Full Text] [Related]
40. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Boudreau RT, Conrad DM, Hoskin DW. Cell Signal; 2007 Jan 29; 19(1):139-51. PubMed ID: 16844342 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]